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A B S T R A C T
Left ventricular pseudoaneurysms are usually associated with acute myocardial infarction; however, 
these conditions may emerge in the late postoperative period of valvar surgery, and this can also occur 
with aortic pseudoaneurysms. These pseudoaneurysms often affect patients with high surgical risk, 
and percutaneous treatment is usually performed in reference centers for treatment of congenital heart 
diseases, due to anatomical characteristics of these defects. We present two cases of left ventricular 
pseudoaneurysms treated by transapical approach without need for cardiopulmonary bypass, and a case 
of aortic pseudoaneurysm treated by femoral approach, in which a snare was introduced by contralateral 
access, to allow for adequate support and guidance of the long sheath for accessing the defect.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Tratamento percutâneo de pseudoaneurismas do ventrículo esquerdo e da aorta: 
série de três casos
R E S U M O
Pseudoaneurismas do ventrículo esquerdo são geralmente associados a infarto agudo do miocárdio, 
entretanto, podem surgir no pós-operatório tardio de cirurgias valvares, assim como os pseudoaneurismas 
aórticos. Acometem frequentemente pacientes com alto risco cirúrgico, e o tratamento percutâneo é 
habitualmente realizado em centros de referência para o tratamento de cardiopatias congênitas devido 
às características anatômicas dos defeitos. Apresentamos dois casos de pseudoaneurismas do ventrículo 
esquerdo tratados por via transapical, sem necessidade de circulação extracorpórea, e um caso de 
pseudoaneurisma aórtico tratado por via femoral, no qual foi utilizado laço por acesso contralateral para 
permitir suporte e direcionamento adequados da bainha longa para acessar o defeito.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Left ventricular pseudoaneurysms usually are the result of left 
ventricular wall rupture after acute myocardial infarction (AMI) 
or heart surgery, with or without valve replacement. The risk of 
rupture is between 30 to 45% in the first year, and surgery is as-
sociated with a mortality of about 20 to 35%.1-5 Percutaneous or 
transapical therapy seems to be a viable, effective and possibly 
safer option.6,7
In the same line, pseudoaneurysms of the ascending aorta are more 
often diagnosed, among other less common causes, in patients who 
has previously undergone aortic surgery.8 In addition to being techni-
cally difficult, patients usually show a not negligible surgical risk, 
making the percutaneous technique an attractive alternative, mainly 
in centers specialized in the treatment of congenital heart defects.
This study reports two cases of left ventricular pseudoaneurysm 
successfully treated by a transapical technique in a hybrid room, and 
a case of pseudoaneurysm of the aorta treated by femoral access.
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Case report
Case 1
This is a 79-year-old female patient with a history of AMI compli-
cated by rupture of left ventricle and formation of pseudoaneurysm. 
During coronary artery bypass graft surgery, it was not possible to 
access the pseudoaneurysm location, due to the extensive presence 
of adhesions, caused by radiotherapy for breast cancer. Thus, we fa-
vored a conservative treatment; however, the patient developed 
heart failure and pseudoaneurysm growing, which reached 6 × 6 cm 
in the last assessment, when the patient was referred to the invasive 
cardiology team to evaluate the possibility of a percutaneous clo-
sure.
During cardiac catheterization, extensive peripheral vascular 
disease was evidenced, which ruled out the feasibility of a percuta-
neous treatment by retrograde route, possibly the best option due to 
the posterior-anterior position of the defect. Thus, our final choice 
was an apical puncture through mini-throracotomy, through which 
a 14 F introducer sheath was inserted in the left ventricular cavity. 
However, due to the unfavorable angle between the short sheath and 
the defect entry, we could not access the defect with a standard long 
sheath for implantation of the occluder device.
After angiography and appropriate location and measurement of 
the defect (15 mm diameter), a long deflectable sheath (FustarTM, 
Lifetech Scientific Inc., Shenzhen, China) was introduced, making 
possible the access to the defect with a catheter, the positioning of a 
stiff guide and, following that, the release of a 20 mm CERATM ASD 
(Lifetech Scientific Inc., Shenzhen, China) device (Fig. 1). This patient 
recovered uneventfully, being discharged after 48 hours of admis-
sion and with a transthoracic echocardiogram without residual 
shunt through the defect. Three months after surgery, the patient 
was asymptomatic.
Case 2
This is a 39-year-old male patient who underwent three previ-
ous heart surgeries. The first of these operations, carried out 14 
years ago, was for a mitral-aortic aneurysm repair. After 1 year, 
the patient developed severe aortic insufficiency, requiring a me-
tallic aortic prosthesis implant. Eight years after the first surgery, 
the patient showed signs of class II NYHA heart failure, and the 
echocardiogram showed moderate-to-severe perivalvar leak and a 
pseudoaneurysm of the ascending aorta. The patient was referred 
for surgical implant of an aortic valved tube, a 25 mm prosthetic 
metallic aortic valve, and coronary reimplantation by Cabrol tech-
nique. Intraoperatively, the patient developed severe bleeding; it 
was necessary to maintain the chest opened with hemostatic pack 
use for 48 hours. Then, the chest was closed, with hemothorax 
drainage. During the postoperative period, the patient showed 
right pleural effusion, sepsis and atrial flutter reverted with elec-
trical cardioversion.
The patient had a good outcome; however, 6 years later, a trans-
thoracic echocardiography was suggestive of residual pseudoaneu-
rysm. A transesophageal echocardiogram showed pulsatile 
sacculation with an ostium located in the left ventricular outflow 
tract between the prosthetic valve ring and the anterior mitral leaf-
let, measuring 4.4 × 2.6 cm. By transapical approach and with an 18 F 
introducer sheath, a catheter was placed inside the defect, and an 
angiography was carried out, revealing a pseudoaneurysm in the 
aortic subvalvar portion with a hole measuring about 4 mm in diam-
eter and a course of approximately 20 mm (Fig. 2A). The defect was 
accessed by means of a hydrophilic guide, which was later replaced 
by a molded extra-rigid guide, from which the 9 F releasing system 
was introduced. Then, an 8-mm AmplatzerTM Muscular VSD device 
(St. Jude Medical Inc., St. Paul, US) was successfully implanted. A 
control ventriculography and an intraoperative transesophageal 
echocardiography showed good positioning of the device, without 
interfering with the prosthetic aortic heart valve dynamics, and 
with minimal residual shunt through the device (Fig. 2B). An echo-
cardiogram carried out 24 hours after the procedure showed com-
plete occlusion of the defect.
Case 3
This is a 58-year-old female patient, with a history of fusiform an-
eurysm of ascending and transverse aorta measuring 6.3 × 6.0 cm, op-
erated 3 years ago. The patient was admitted because of syncope and 
chest pain. A catheterization was carried out, revealing a distal saccu-
lar aneurysmal region in the ascending aorta, probably corresponding 
to a pseudoaneurysm at the suture area. Due to the presence of a previ-
ous surgery and considering the high surgical risk, we opted for a tech-
nique of percutaneous occlusion of the pseudoaneurysm.
The technical challenge to be overcome in this case was the loca-
tion of the pseudoaneurysm, just below the insertion of the innomi-
nate artery. The location prevented access through the right 
subclavian artery; thus, direct positioning of the long sheath into the 
aneurysm became a risky task, due to system tension. Our solution 
was to control the sheath positioning through a support snare. A 
20-mm snare was introduced from the radial artery; this device was 
left open into the ascending aorta, near the aortic valve. Then, a long 
sheath, compatible with an appropriately sized prosthesis for defect 
occlusion, was introduced up to the ascending aorta. The distal part 
of the sheath was captured by the snare and brought to the pseudoa-
neurysm orifice. Using the support provided with the use of this 
snare, the sheath was gently introduced into the cavity, without put-
ting pressure on its walls. The snare was maintained until the intro-
duction of the Amplatzer ASO (15 mm St. Jude Medical Inc., St. Paul, 
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Figure 1. (A) Deflectable sheath positioned toward a left ventricular pseudoaneurysm, 
with catheter and its extra-rigid guide positioned within the defect. (B) First disc of 
the device disc released within the defect through the deflectable sheath.
Figure 2. (A) Angiography with catheter inside the left ventricular pseudoaneurysm, 
close to the aortic prosthesis, showing the defect anatomy. (B) Ventriculography after 
device implantation, with mild residual shunt through the device.
 J. L. L. Manica et al. / Rev Bras Cardiol Invasiva. 2015;23(1):73-76 75
USA) device, thus allowing that there was no retrocession or loss of 
position when the distal disk of the device was open. The prosthesis 
was released in the usual way, after confirmation by an angiogram 
of an adequate position of the device; with this, the snare was 
opened, releasing the long sheath (Fig. 3).
The evolution of the patient had no further complications, but 3 
years after the procedure, she was hospitalized with hypotension 
and chest pain. An angiotomography revealed the presence of a dis-
secting aneurysm of the ascending aorta, which was surgically cor-
rected. During the intraoperative period, the patient developed 
massive airway bleeding and died probably due to an aortopulmo-
nary fistula.
Discussion
Historically, both left ventricular pseudoaneurysm as aortic 
pseudoaneurysm are treated surgically. However, these two prob-
lems often occur in previously operated patients with surgical adhe-
sions that hinder the intraoperative management, and with 
comorbidities leading to a high procedural mortality. In this scenar-
io, it is not uncommon that some patients have surgical contraindi-
cations due to the severity of their condition. From this context, 
percutaneous treatment by femoral or transapical approach has 
been gaining space and has become a viable alternative, with satis-
factory results.6,7
In most cases, the diagnosis can be established by transthoracic 
echocardiography. A ratio < 0.5 between neck diameter and inner 
diameter of the aneurysmal sac suggests a diagnosis of pseudoaneu-
rysm. Chest CT angiography and three-dimensional transesopha-
geal echocardiography help in planning the intervention and in the 
choice of the device, by determining the anatomical characteristics 
of the aneurysmal sac and also of the neck of the defect.2 Further-
more, it is critical to determine the relations of the defect with adja-
cent structures.8-10
Left ventricular pseudoaneurysms usually result from rupture of 
the left ventricular wall, which is temporarily restrained by scar tis-
sue, thereby avoiding pericardial tamponade or free bleeding to the 
pleural cavity. However, the risk of rupture is around 30 to 45% in 
the first year. It usually occurs after AMI or a surgical valve replace-
ment. Less frequently, the rupture may occur after a pacemaker im-
plant, resection of a left ventricular aneurysm, Ross surgery or 
percutaneous aortic valve implant.2-7,11,12 Clinically, left ventricular 
pseudoaneurysm may occur in an asymptomatic patient, in a pa-
tient with chest pain, or even causing symptoms of congestive heart 
failure. Surgical repair is the most widely described treatment; 
however, its high risk and the presence of previous surgery in most 
patients have made percutaneous therapy a viable, effective and 
possibly safer option.6,7
As described in the literature, in this study two cases were suc-
cessfully treated by direct left ventricular puncture, without cardio-
pulmonary bypass, using percutaneous occlusion techniques for 
congenital heart disease. Considering that this is an acquired cardi-
opathy with several etiologies, there is a number of measures and 
neck size and location that corroborates an individualized approach 
with respect to access and to the device.7
Initially described by Clift et al.,4 approximately 19 cases have 
been published in the literature, with many devices of common use 
in the treatment of congenital heart disease being used off-label, 
such as septal occluders of interatrial or muscular interventricular 
communications, and vascular plugs. In general, these defects are 
occluded by a percutaneous retrograde access through the femoral 
artery, or else, by a transapical access through a mini-thoracoto-
my.3-7,11-16 In the two cases presented in this study, the transapical 
approach was used. In the first case, thanks to the extensive periph-
eral vascular disease; and in the second case, because of the proxim-
ity and the unfavorable angle close to the aortic valve.
In the first case, even using direct left ventricular cavity punc-
ture, the angle between the inserted sheath and the neck of the de-
fect was not favorable for introduction of a long and free-of-tension 
large-bore sheath. After multiple unsuccessful attempts, we opted 
for the use of a deflectable sheath, which was easily introduced until 
reaching the defect entry and allowed for a successful implant of the 
device. Since this was a large defect with a shallow neck, it was de-
cided to use a device for atrial septal defect occlusion, which was 
adequate for this type of defect.
In the second case, the apical puncture allowed coaxial access to 
the defect close to the aortic valve, permitting the implantation of 
the device to be carried out safely, effectively and without major dif-
ficulties with a 6 F catheter. In this case, we chose an interventricu-
lar defect closure device, because this defect had an extensive neck, 
and also because type II vascular plugs were temporarily unavail-
able. Both cases were performed at the same institution, in a hybrid 
room and with a team of professionals accustomed with team work 
(Heart Team).
Pseudoaneurysms of the ascending aorta, although well-known 
entities, are uncommon, with potentially fatal complications. These 
defects occur most often after reconstructive surgery of the aorta 
and valve repair, and less often after chest trauma or infection.10
The regions potentially amenable to the emergence of pseudo-
aneurysms of the ascending aorta are those sites of cannulation and 
aortic clamping, and graft suture zones.9 Some complications related 
to surgical technique, graft or tissue degeneration, as well as deteri-
oration of suture material are among the causes commonly associ-
ated with the development of pseudoaneurysms of the aorta.
The behavior of this defect is similar to that of pseudoaneurysms 
of the left ventricle, i.e., there is risk of rupture, thrombosis and dis-
tal embolization, and of fistula formation.8 The standard treatment 
is surgical, but the risk can reach 30% and sometimes this option is 
not technically or clinically feasible.
In patients with clinical manifestations, the most common pre-
sentations are myocardial ischemia due to coronary compression, a 
chest pulsatile mass, skin ulceration and subsequent bleeding, em-
bolic events and complications related to infection and/or pseudoa-
neurysm rupture.
Percutaneous occlusion of pseudoaneurysms of the aorta was 
first described in 2005 in a patient with a prohibitive surgical risk.8 
Figure 3. (A) Aortography showing a pseudoaneurysm of the ascending aorta. (B) A snare 
in the ascending aorta through contralateral radial access. (C) Snare facilitating the access 
of a long sheath to the defect. (D) Beginning of device release. (E) A well-positioned de-
vice, still attached to the delivery cable. (F) Aortography without residual shunt.
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Based on the experience of septal occluders in congenital heart de-
fect patients; we chose to use this technique in our patient, with an 
excellent and immediate result. One of the setbacks often encoun-
tered in using this technique is the tension generated by the long 
sheath during the access towards the defect, besides the intrinsic 
difficulty of access. The literature describes some alternatives to fa-
cilitate implantation and minimize risks. Bashir et al.,8 after numer-
ous unsuccessful attempts, described the use of a Hausdorff sheath 
(Cook Medical Inc., Bloomington, USA), which enabled a successful 
implantation. According to Stark et al.,17 the customization of the 8F 
introducer sheath with a “hockey stick” guide-catheter is required, 
and this also permitted the access to the defect and percutaneous 
occlusion of the pseudoaneurysm, with adequate result. However, 
depending on the location and size of the isthmus of entry for the 
defect, the occlusion with an AmplatzerTM device may be beyond 
question, for instance, in the case of an isthmus larger than the 
prosthesis, or when there would be risk of occlusion of supra-aortic 
vessels.
As described in the literature, in this case the main difficulty was 
the access to the defect with the long sheath. To overcome this limi-
tation, the authors describe a technique that uses an contralateral 
access snare, which lends adequate support and direction for the 
long sheath, without causing significant tension in the aortic wall.
This case clearly elucidates that percutaneous aortic pseudo-
aneurysm occlusion in selected cases is a safe and viable alternative 
to surgical procedure, with fewer risks related to the procedure and 
less short-term complications. However, it is critical that the opera-
tor has experience in percutaneous occlusion, which may result in 
higher success rates.
In addition, the Heart Team cooperation and the provision of a 
hybrid room at our institution were extremely important in our ini-
tial experience in the treatment of left ventricular pseudoaneu-
rysms; thus, it was shown that teamwork results in a wide range of 
patients with the possibility of a safer and more effective treatment.
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